Page last updated: 2024-08-18

cyclohexanol and Cholera Infantum

cyclohexanol has been researched along with Cholera Infantum in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (37.50)	18.2507
2000's	5 (62.50)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hackett, D; Lydiard, RB; Pitrosky, B; White, C	1
Ahmed, S; Dunner, DL; Ferguson, JM; Friedman, ES; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kocsis, JH; Kornstein, SG; Musgnung, J; Nemeroff, CB; Ninan, PT; Pedersen, RD; Rothschild, AJ; Schatzberg, AF; Shelton, RC; Thase, ME; Trivedi, MH; Yan, B; Zajecka, JM	1
Kornstein, SG	1
Farah, A; Lauer, TE	1
Agelink, MW; Klieser, E; Zitzelsberger, A	1
Anand, VS; Dewan, MJ	1
Abbar, M; Blayac, JP; Giniès, E; Peyrière, H; Pinzani, V; Robert, L	1
Dagge, A; Holzinger, J; Hornik, L; Körfer, R; Minami, K; Mirow, N; Schulz, U; Tenderich, G	1

Reviews

3 review(s) available for cyclohexanol and Cholera Infantum

Article	Year
Impact of gastrointestinal symptom severity on response to venlafaxine extended-release in patients with generalized anxiety disorder. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:6 Topics: Adult; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2004
Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study. Expert review of neurotherapeutics, 2008, Volume: 8, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Double-Blind Method; Female; Fluoxetine; Gastrointestinal Diseases; Headache; Humans; Hypertension; Male; Middle Aged; Respiratory Tract Infections; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride	2008
[Venlafaxine withdrawal syndrome: report of six cases and review of the literature]. La Revue de medecine interne, 2000, Volume: 21, Issue:3 Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Hallucinations; Headache; Humans; Male; Middle Aged; Paresthesia; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Time Factors; Venlafaxine Hydrochloride	2000

Trials

1 trial(s) available for cyclohexanol and Cholera Infantum

Article	Year
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:8 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Double-Blind Method; Female; Fluoxetine; Gastrointestinal Diseases; Headache; Humans; Hypertension; Male; Middle Aged; Respiratory Tract Infections; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride	2007

Article

Year

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.

The Journal of clinical psychiatry, 2007, Volume: 68, Issue:8

Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Double-Blind Method; Female; Fluoxetine; Gastrointestinal Diseases; Headache; Humans; Hypertension; Male; Middle Aged; Respiratory Tract Infections; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride

2007

Other Studies

4 other study(ies) available for cyclohexanol and Cholera Infantum

Article	Year
Possible venlafaxine withdrawal syndrome. The American journal of psychiatry, 1996, Volume: 153, Issue:4 Topics: Adult; Cyclohexanols; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Headache; Humans; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride	1996
Withdrawal syndrome after discontinuation of venlafaxine. The American journal of psychiatry, 1997, Volume: 154, Issue:10 Topics: Age Factors; Aged; Cyclohexanols; Depressive Disorder; Female; Gastrointestinal Diseases; Headache; Humans; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1997
Evaluating the tolerability of the newer antidepressants. The Journal of nervous and mental disease, 1999, Volume: 187, Issue:2 Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delayed-Action Preparations; Drug Information Services; Fluvoxamine; Gastrointestinal Diseases; Guidelines as Topic; Humans; Incidence; Paroxetine; Piperazines; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles; United States; United States Agency for Healthcare Research and Quality; Venlafaxine Hydrochloride	1999
Successful use of cardiac allograft from serotonin antagonist intoxication. Transplantation, 2001, Aug-15, Volume: 72, Issue:3 Topics: Adult; Antidepressive Agents; Cyclohexanols; Fluoxetine; Gastrointestinal Diseases; Heart Transplantation; Humans; Male; Postoperative Complications; Serotonin Antagonists; Suicide; Transplantation, Homologous; Venlafaxine Hydrochloride	2001